Discussing the latest TKI approval, umbralisib, and its familiar toxicity profile.  Also, a few final words on a new CAR-T product and a cemiplimab expanded approval.

Filgrastim Turns 30

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.